SurgoCap Partners LP

Q4 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2024
Date filed
2/14/2025
Form type
13F-HR
Num holdings
12
Total value ($000)
$1,940,736
Net value change ($000)
-61,784 (-3.1%)
New positions
2
Sold out positions
3
Turnover %
49.7%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/14/2024 Next filing: 5/15/2025 SEC filing

Snapshot: Change Analysis

Compared to Q3 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
NVDA 139,678 NEW
CRS 138,978 131.4%
HLT 109,492 NEW
LPLA 49,965 27.5%
BX 43,251 35.3%
GEHC 14,887 9.3%
GWRE 10,977 8.7%
Top Reduces (Value $000, Stocks/ETFs)
GEV -300,036 -100.0%
AAPL -165,828 -100.0%
SNPS -142,856 -100.0%
NU -21,517 -22.5%
META -14,060 -8.1%
MCK -10,748 -3.6%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 213,523 (11.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type